Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis
NCT00572897
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
66
Enrollment
OTHER
Sponsor class
Conditions
Myelofibrosis
Interventions
DRUG:
Fludarabine, Melphalan +/- ATG
Sponsor
John Mascarenhas
Collaborators
[object Object]
[object Object]
[object Object]